Blood cancer death rates have dipped in recent decades, dramatically boosting 5-year survival rates in leukemia, lymphoma, and myeloma. Still, the three diseases were expected to kill more than 57,000 people in the United States in 2023 — almost 10% of all cancer deaths. As a result…
